Product image of Linezolid Ascend (Linezolid) supplied by GNH India

Linezolid Ascend

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Ascend (Linezolid)

Linezolid, the active ingredient in Linezolid Ascend, is an oxazolidinone antibiotic presented as an oral formulation for systemic use. It treats infections caused by resistant Gram‑positive bacteria, including MRSA and VRE, in adult patients.
GNH India supplies Linezolid Ascend as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ascend Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive infections.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides bacteriostatic activity against resistant strains, facilitating infection clearance.
  • Vancomycin‑resistant Enterococcus (VRE) infections: effective where other agents fail, helping to resolve invasive disease.
  • Community‑acquired pneumonia: targets typical and atypical pathogens, improving respiratory outcomes.
  • Skin and soft tissue infections: combats resistant skin pathogens, aiding wound healing and symptom relief.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations, disrupting growth of Gram‑positive bacteria including resistant strains.

Side Effects

Linezolid may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Metallic taste: altered taste perception.
  • Rash: mild skin erythema.
  • Vomiting: occasional emesis.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Peripheral neuropathy: nerve pain or sensory changes, potentially irreversible.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Myelosuppression: bone‑marrow suppression affecting blood cell lines.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuritis: visual disturbances requiring urgent evaluation.

Precautions & Warnings

Use of Linezolid requires careful clinical assessment.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic agents: avoid to reduce risk of serotonin syndrome.
  • Mitochondrial toxicity: watch for signs of neuropathy or lactic acidosis.
  • Pregnancy: risk unknown; prescribe only if benefits outweigh potential hazards.
  • Store at room temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Linezolid interacts with several drug classes that may alter efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): can precipitate hypertensive crisis.
  • Serotonergic antidepressants (SSRIs, SNRIs, TCAs): increase risk of serotonin syndrome.
  • Tyramine‑rich foods: may cause hypertensive reactions due to MAO inhibition.

Moderate Interactions (Monitor Closely)

  • Rifampin: induces metabolism, reducing linezolid plasma levels.
  • Antacids containing magnesium or aluminum: may decrease absorption; separate dosing by at least 2 hours.
  • Warfarin: potential alteration of anticoagulant effect; monitor INR.

Frequently Asked Questions

Linezolid Ascend is indicated for infections caused by resistant Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired pneumonia, and skin and soft‑tissue infections. It is prescribed when other antibiotics are ineffective or contraindicated.

Linezolid binds to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, providing a bacteriostatic effect against most susceptible organisms and a bactericidal effect at higher concentrations.

The specific dose and treatment duration are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for linezolid in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician in consultation with the patient.

To request Linezolid Ascend, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Linezolid offers oral administration and activity against both MRSA and VRE, whereas vancomycin is administered intravenously and lacks efficacy against VRE. Linezolid may be preferred for patients requiring oral therapy or when vancomycin resistance is present, but each agent has distinct safety profiles that guide selection.

Linezolid Ascend should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Linezolid Ascend is taken orally, usually as a tablet or oral suspension, according to the prescriber’s instructions. It should be swallowed whole with water and taken at evenly spaced intervals to maintain consistent blood levels.

Serious risks include thrombocytopenia, peripheral neuropathy, serotonin syndrome when combined with serotonergic drugs, myelosuppression, and rare metabolic disturbances such as lactic acidosis. Patients should be monitored regularly for blood‑count changes and neurological symptoms.

Linezolid Ascend is contraindicated in patients with known hypersensitivity to linezolid or any oxazolidinone component. Caution is advised for individuals on MAO inhibitors, serotonergic agents, or those with uncontrolled hypertension, as well as patients with severe hepatic or renal impairment where alternative therapy may be preferable.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT